Reseña del libro "Future Now? The art of Imagination (en Inglés)"
What could you accomplish if you could anticipate what the future might look like – and shape it into the future you want? If you’re in pharma, you’re planning ahead ten or twenty years with every commitment you make to a new drug or research and development investment. You’re spending billions on a long shot – a bet that the future will recognize the value of what you’ve created, and reward you for it. But how much are you spending to shape that future into one that will be receptive to the therapies you’re selling? While nobody can predict the future, major corporations whose futures depend on making smart choices now rely on Futuring. Why? Futuring informs a new hyperawareness of the environment at large, allowing you to see the significance in events you might not otherwise spot. Once you learn the methods, tools, and skills to imagine a variety of “futures”, you are empowered to actually shift the future’s direction, not just ride its wake. And while Futuring isn’t new, the way in which we at Simpson Healthcare have adapted it to the current, time-compressed world of healthcare, is. The Speed Futuring approach outlined in this book will set you on your way to shape and prepare for your company’s future, with leadership and presence.About the Authors: Kelly Simpson, Founder, CSO, CEO of Simpson Healthcare and Chief Collaborative Officer at Summit Global Health began her career in Pharma as a Research Scientist at Pfizer. Her multi-award-winning company, Simpson Healthcare, is an established scientific agency whose employees provide the pharmaceutical, biotechnology, health technology, diagnostic and device industries with a wide range of disruptive solutions and content services in support of overall marketing strategies in health and disease. Erin Conlan, Managing Director, Simpson Healthcare, began her career as a researcher at Pfizer in the Natural Products and Metabolism Laboratories. She departed research and development in search of a place where her expertise in biology, education, and communications could be better leveraged. She found a home at Simpson Healthcare, where for 20 years she has been focused on dissecting and simplifying the science, crafting compelling scientific narratives, and delivering that information to the right person at the right moment to evolve and humanize patient care. More recently, through her experience as a caregiver to a patient with a rare disease, she’s developed a passion focused on ways to build health and impact wellness more broadly.Sheryl Torr-Brown, PhD, SVP Medical, Simpson Healthcare, has diverse experience of the healthcare environment including research and development for Astra Zeneca, Searle, Monsanto and Pfizer, design innovation including pharmacy of the future with CVS/Caremark, and market research/product development for numerous healthcare offerings including devices for eye health and equine rehabilitation. At Simpson Healthcare, Sheryl is committed to exploration across boundaries, with a passion for deep innovation in medical strategy and the development of health-related content that moves people.
